Squarepoint Ops LLC Corbus Pharmaceuticals Holdings, Inc. Transaction History

Squarepoint Ops LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	SELL	$1.27 - $3.42 $368,975 - $993,619	-290,532 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$0.94 - $1.89 $207,275 - $416,756	220,506 Added 314.89%	290,532 $363,000
Q3 2020 Nov 16, 2020	SELL	$1.5 - $9.38 $112,671 - $704,569	-75,114 Reduced 51.75%	70,026 $126,000
Q2 2020 Aug 14, 2020	BUY	$4.79 - $8.39 $695,220 - $1.22 Million	145,140 New	145,140 $1.22 Million
Q4 2019 Feb 14, 2020	SELL	$4.29 - $5.64 $112,174 - $147,474	-26,148 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$4.87 - $7.08 $127,340 - $185,127	26,148 New	26,148 $127,000
Q2 2018 Aug 14, 2018	SELL	$5.05 - $6.8 $121,836 - $164,056	-24,126 Closed	0 $0
Q1 2018 May 15, 2018	SELL	$5.6 - $9.25 $39,205 - $64,759	-7,001 Reduced 22.49%	24,126 $147,000
Q4 2017 Feb 14, 2018	BUY	$6.6 - $7.78 $205,438 - $242,168	31,127	31,127 $221,000

38.7K

Ticker CRBP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 125,268,000
Market Cap $724M
Description
Corbus Pharmaceuticals Holdings, Inc., a biopharmaceutical company, focuses on the development of immune modulators for immuno-oncology and fibrosis diseases. It develops lenabasum, an oral molecule that selectively activates cannabinoid receptor type 2 (CB2), which is in Phase II clinical trial to treat systemic lupus erythematosus; CRB-601, an...

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

Stay updated on Squarepoint Ops LLC with notifications on news.